上药康丽（常州）药业有限公司
Shanghai Pharma Group Changzhou Kony Pharmaceutical Co. Ltd. Luoyang Town Cn
Country: CN CDE+DMF+CEP MEDIUM
🇨🇳 CDE
20
20 products shown
🇺🇸 DMF
1
1 products shown
🇪🇺 CEP
5
5 products shown
Total
26
registrations
🇨🇳 CDE 注册 (20)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Aciclovir 阿昔洛韦 | 59277-89-3 | Class A | Y20190008023 |
| Ciclopirox 环吡酮胺 | 29342-05-0 | Class A | Y20190004749 |
| Cinacalcet 盐酸西那卡塞 | 226256-56-0 | Class A | Y20210000300 |
| Eslicarbazepine Acetate 醋酸艾司利卡西平 | 104746-04-5 | Class I | Y20180000972 |
| Famciclovir 泛昔洛韦 | 104227-87-4 | Class A | Y20190004750 |
| Ganciclovir 更昔洛韦 | 82410-32-0 | Class A | Y20190009666 |
| Isavuconazole 硫酸艾沙康唑 | 241479-67-4 | Class A | Y20230001128 |
| Lacosamide 拉考沙胺 | 175481-36-4 | Class A | Y20200001262 |
| Lacosamide 拉考沙胺 | 175481-36-4 | Class A | Y20200000522 |
| Linacotrivir 戊二酸利那拉生酯 | 255382-26-4 | Class I | Y20240001411 |
| Penciclovir 喷昔洛韦 | 39809-25-1 | Class A | Y20190004751 |
| Perindopril Tert-butylamine 培哚普利叔丁胺盐 | 82834-16-0 | Class A | Y20220000732 |
| Rabeprazole Sodium 雷贝拉唑钠 | 117976-89-3 | Class A | Y20190009667 |
| Roxadustat 罗沙司他 | 808118-40-3 | Class A | Y20220000483 |
| Safinamide 甲磺酸沙非胺 | 133865-89-1 | Class I | Y20240001565 |
| Tamsulosin 盐酸坦索罗辛微丸 | 106133-20-4 | Class A | Y20230001135 |
| Valaciclovir 盐酸伐昔洛韦 | 124832-26-4 | Class A | Y20190008036 |
| Valacyclovir (anhydrous) 盐酸伐昔洛韦(无水物) | 24214-86-6 | Class A | Y20190000210 |
| Valganciclovir 盐酸缬更昔洛韦 | 175865-60-8 | Class A | Y20210000090 |
| Valsartan 缬沙坦 | 137862-53-4 | Class A | Y20190009668 |
🇺🇸 DMF 注册 (1)
| Product | CAS | DMF Number | Date |
|---|---|---|---|
| Acyclovir 阿魏酸钠 | 503612-47-3 | - | 2021-08-18 |
🇪🇺 CEP 注册 (5)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Ciclopirox 环吡酮胺 | 29342-05-0 | CEP 2019-102 - Rev 02 | - |
| Ciclopirox Olamine 环吡酮胺 | 41621-49-2 | R1-CEP 2012-253 - Rev 02 | - |
| Ganciclovir 更昔洛韦 | 82410-32-0 | CEP 2024-086 - Rev 00 | - |
| Tamsulosin Hydrochloride 盐酸坦索罗辛微丸 | 106133-20-4 | CEP 2024-421 - Rev 00 | - |
| Valganciclovir Hydrochloride 盐酸缬更昔洛韦 | 175865-59-5 | CEP 2024-326 - Rev 00 | - |
Source: ema_cep;FDA_DMF | Updated: 2026-04-09 07:23:02